Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TOGA: Oxygen for Gastrointestinal Atony
NCT03386136Phase 1Completed
- Sponsor
- University of Florida
- Start
- Jan 2018
- Primary completion
- Oct 2019
- Modality
- Inhalation Devices
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of oxygen in ileus, Ogilvie syndrome (ACPO) and small bowel obstruction (SBO), sponsored by University of Florida. Primary endpoints: Changes in Diameter of Colon at 24 hours and Changes in Diameter of the Small Bowel at 24 hours. Started Jan 2018; status: completed.
02
Drugs
oxygen
03
Conditions
ileusOgilvie syndrome (ACPO)small bowel obstruction (SBO)
Beyond the preview
Go deeper on NCT03386136.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03386136.